通过抵消NMDAR2B裂变,MET基因增强了亲迁移功能
Simona Gallo1,2, Annapia Vitacolonna1,2, Paolo Maria Comoglio3
1Department of Oncology, University of Turin, Regione Gonzole 10, 10143 Orbassano, Italy.
Cells
|January 11, 2024
概括
MET受体激酶保护N-甲基-D-酸盐受体子单元2B (NMDAR2B) 免受 lysosomal 降解,增强癌细胞迁移. MET激酶活性对这种保护机制至关重要,影响癌症入侵.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- N-甲基-D-酸盐受体 (NMDAR) 与癌细胞入侵有关.
- 之前已经观察到NMDAR和肝细胞生长因子 (HGF) 受体MET之间的物理相互作用.
- 控制NMDAR/MET相互作用的精确分子机制及其在癌症中的功能后果在很大程度上是未知的.
研究的目的:
- 阐明NMDAR和MET之间的相互作用背后的分子机制.
- 研究MET在调节NMDAR稳定性和功能的作用.
- 确定MET-NMDAR轴如何影响癌细胞迁移.
主要方法:
- 细胞中NMDAR2B和MET结构的同时传染.
- 评估NMDAR2B的蛋白质分解加工和蛋白质水平.
- 抑制自和溶酶体通路.
- 分析MET激酶活性及其对NMDAR2B的影响.
- 细胞迁移试验的评估.
主要成果:
- NMDAR2B经过蛋白质分解处理以达到100kDa的形式,该形式通过MET共同表达得到稳定.
- MET激酶活性对于保护NMDAR2B免受裂变至关重要.
- 通过降低甲素水平,MET抑制了NMDAR2B的自 lysosomal蛋白解,并且依赖于mTOR信号传递.
- MET使用NMDAR2B来促进癌细胞迁移.
结论:
- MET激酶活性通过防止其溶酶体降解来稳定NMDAR2B,从而增强癌细胞迁移.
- 通过MET介导的NMDAR2B对自的保护是一种新的机制,有助于癌细胞的侵入性.
- 针对MET-NMDAR相互作用可以提供一种治疗策略,以抑制癌症的进展.
更多相关视频
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
1.8K
09:45Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
11.2K
相关概念视频
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
